603368 Stock Overview
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Guangxi LiuYao Group Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥21.50 |
52 Week High | CN¥25.80 |
52 Week Low | CN¥15.12 |
Beta | 0.34 |
1 Month Change | -0.14% |
3 Month Change | 19.25% |
1 Year Change | -7.21% |
3 Year Change | -5.49% |
5 Year Change | -17.58% |
Change since IPO | 45.08% |
Recent News & Updates
A Look At The Fair Value Of Guangxi LiuYao Group Co., Ltd (SHSE:603368)
Apr 18Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 04Shareholder Returns
603368 | CN Healthcare | CN Market | |
---|---|---|---|
7D | 2.6% | 1.9% | 1.6% |
1Y | -7.2% | -32.4% | -15.1% |
Return vs Industry: 603368 exceeded the CN Healthcare industry which returned -32.4% over the past year.
Return vs Market: 603368 exceeded the CN Market which returned -15.1% over the past year.
Price Volatility
603368 volatility | |
---|---|
603368 Average Weekly Movement | 4.9% |
Healthcare Industry Average Movement | 6.8% |
Market Average Movement | 8.8% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 603368's share price has been volatile over the past 3 months.
Volatility Over Time: 603368's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 5,162 | Chaoyang Zhu | web.lzyy.cn |
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.
Guangxi LiuYao Group Co., Ltd Fundamentals Summary
603368 fundamental statistics | |
---|---|
Market cap | CN¥7.74b |
Earnings (TTM) | CN¥846.76m |
Revenue (TTM) | CN¥20.81b |
9.1x
P/E Ratio0.4x
P/S RatioIs 603368 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603368 income statement (TTM) | |
---|---|
Revenue | CN¥20.81b |
Cost of Revenue | CN¥19.77b |
Gross Profit | CN¥1.04b |
Other Expenses | CN¥193.45m |
Earnings | CN¥846.76m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | 2.35 |
Gross Margin | 5.00% |
Net Profit Margin | 4.07% |
Debt/Equity Ratio | 66.9% |
How did 603368 perform over the long term?
See historical performance and comparison